APP and Alzheimer disease: Therefore, these findings strongly support that δ-secretase is required for initiating AD-like pathologies, even though both wild-type human APP and human Tau are amply upregulated, highlighting that δ-secretase plays a key role in the initiation of AD pathogenesis.